| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/16/1999 | EP0921804A1 Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| 06/16/1999 | EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 06/16/1999 | CN1219938A Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 06/16/1999 | CN1219872A Compositions and method for treating or preventing diseases of body passageways |
| 06/16/1999 | CN1219429A Baby's mother health granulae and its processing method |
| 06/16/1999 | CN1219419A Cat-tail pollen pill |
| 06/16/1999 | CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them |
| 06/15/1999 | US5912346 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 06/15/1999 | US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease |
| 06/15/1999 | US5912265 Administering silymarin, silybin, silidianin, silicristin, dehydrosilybin or mixtures; antitumor and anticarcinogenic agents |
| 06/15/1999 | US5912244 Muscle disorders, breathing disorders and urinary incontinence |
| 06/15/1999 | US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases |
| 06/15/1999 | US5912005 Methods of use of uncoated gel particles |
| 06/10/1999 | WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/10/1999 | WO1999028337A1 15-methyl-cyclopropanosteroids and method for the production thereof |
| 06/10/1999 | WO1999028325A1 Thienopyrimidines |
| 06/10/1999 | WO1999027925A1 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
| 06/10/1999 | WO1999027905A1 Compositions for nasal administration |
| 06/10/1999 | WO1999009964A3 Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections |
| 06/10/1999 | DE19753363A1 15-Methyl-cyclopropanosteroide und Verfahren zu ihrer Herstellung 15-methyl-cyclopropanosteroide and processes for their preparation |
| 06/10/1999 | CA2309228A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 06/09/1999 | EP0921124A1 Benzothiophene derivatives useful in therapy |
| 06/09/1999 | EP0920863A1 2-Aryl-3-aroylbenzo(b)thiophenes useful for the treatment of estrogen deprivation syndrome |
| 06/09/1999 | EP0920862A1 2-Arylbenzo b thiophenes useful for the treatment of estrogen deprivation syndrome |
| 06/09/1999 | EP0920510A1 GnRH-LEUKOTOXIN CHIMERAS |
| 06/09/1999 | EP0920504A2 Voltage-gated calcium channel antagonist and methods |
| 06/09/1999 | EP0920503A2 A novel human leptin receptor gene-related protein |
| 06/09/1999 | EP0920431A1 Thienopyrimidines |
| 06/09/1999 | EP0920319A1 Antagonists of gonadotropin releasing hormone |
| 06/09/1999 | EP0751932B1 Vitamin-d amide derivatives |
| 06/09/1999 | CN1219174A Inhibitors of protein farnesyl transferase |
| 06/09/1999 | CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine |
| 06/09/1999 | CN1218688A Seed pill for curing menoxenia |
| 06/09/1999 | CN1218682A Bathing medicine for preventing and curing vulva disease |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910568 Molecule involved in binding of sperm to egg surfaces and procedures for use of this molecule to enhance or decrease potential fertility |
| 06/08/1999 | US5910451 Trophinin and trophinin-assisting proteins |
| 06/08/1999 | US5910316 Concentrated and localized release of no at a given site in a controllable and predictable manner such that effective dosing can be realized |
| 06/08/1999 | US5910305 Process for enhancing fetus fixation of a pregnant animal to prevent abortion |
| 06/08/1999 | CA2255165A1 Benzothiophene derivatives useful in therapy |
| 06/03/1999 | WO1999027095A1 Human cdc10 homolog |
| 06/03/1999 | WO1999026962A1 Androgenic steroid compounds and a method of making and using the same |
| 06/03/1999 | WO1999026655A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor |
| 06/03/1999 | WO1999026631A1 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 06/03/1999 | WO1999026556A1 Biodegradable intra vaginal devices |
| 06/03/1999 | WO1999005096A3 Urokinase inhibitors |
| 06/03/1999 | WO1998058957A9 Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 06/03/1999 | CA2311809A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor |
| 06/03/1999 | CA2311448A1 Androgenic steroid compounds and a method of making and using the same |
| 06/03/1999 | CA2310540A1 Human cdc10 homolog |
| 06/02/1999 | EP0918859A1 Testis-specific insulin homolog polypeptides |
| 06/02/1999 | EP0918857A1 Human induced tumor protein |
| 06/02/1999 | EP0918522A1 Antagonists of gonadotropin releasing hormone |
| 06/02/1999 | EP0918455A1 Galanin |
| 06/02/1999 | EP0757718A4 Methods of use of uncoated gel particles |
| 06/02/1999 | EP0548254B1 6- or 7-(imidazolidin-2-ylideneamino)-1,4-benzoxazines as alpha adrenergic agents |
| 06/02/1999 | DE19752952A1 Thienopyrimidine Thienopyrimidines |
| 06/02/1999 | CN1218456A Irreversible inhibitors of tyrosine kinases |
| 06/02/1999 | CN1218409A Stimulation of host defence mechanisms against viral challenges |
| 06/02/1999 | CN1218402A Improvement of implantation rates after vitro fertilization |
| 06/02/1999 | CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 06/02/1999 | CN1217925A Pregrant powder and preparing method therefor |
| 06/01/1999 | US5908853 Therapy for sexual disorders |
| 06/01/1999 | US5908829 Use of MCP-1 for inducing ripening of the cervix |
| 06/01/1999 | US5908638 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 05/27/1999 | WO1999025863A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 05/27/1999 | WO1999025815A2 Nucleic acids involved in the responder phenotype and applications thereof |
| 05/27/1999 | WO1999025714A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 05/27/1999 | WO1999025707A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME |
| 05/27/1999 | WO1999025706A1 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/27/1999 | WO1999025368A1 A medicine for treating algomenorrhea and the method of preparation thereof |
| 05/27/1999 | WO1999025360A2 Progestogen-antiprogestogen regimens |
| 05/27/1999 | WO1999025348A1 5-ht1f agonists |
| 05/27/1999 | WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 05/27/1999 | WO1999014346A3 SENSE mRNA THERAPY |
| 05/27/1999 | CA2310248A1 5-ht1f agonists |
| 05/27/1999 | CA2309904A1 Transfection and transfer of male germ cells for generation of transgenic species |
| 05/27/1999 | CA2309859A1 2-arylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/27/1999 | CA2309824A1 2-aryl-3-aroylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/27/1999 | CA2309745A1 Progestogen-antiprogestogen regimens |
| 05/26/1999 | EP0917572A2 Secreted proteins and polynucleotides encoding them |
| 05/26/1999 | EP0917466A1 Oral contraceptive |
| 05/26/1999 | EP0836506A4 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 05/26/1999 | CN1217719A Novel benzofuranone derivative and process for producing same |
| 05/26/1999 | CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF) |
| 05/25/1999 | US5906993 Anticancer, antitumor agent |
| 05/25/1999 | US5906979 Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility |
| 05/25/1999 | CA2120062C Use of sulodexide and of medicines containing it in the treatment of diabetic nephropathy |
| 05/25/1999 | CA2011452C Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7,17)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one |
| 05/20/1999 | WO1999024565A1 Methods and compositions for immunomodulation |
| 05/20/1999 | WO1999024433A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 05/20/1999 | WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 05/20/1999 | WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/20/1999 | WO1999024027A2 Anti-estrogen plus progestin containing oral contraceptives |
| 05/20/1999 | CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 05/20/1999 | CA2307210A1 Anti-estrogen plus progestin containing oral contraceptives |
| 05/19/1999 | EP0916727A2 Novel LysS |